Abstract
Nonalcoholic fatty liver disease (NAFLD) is defined by excessive triglyceride deposition in liver, excluding alcoholic or drug factors. NAFLD has grown into a public health concern since it is a leading cause of chronic liver disease in wealthy areas due to obesity and its associated metabolic syndrome. NAFLD has two typical types: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). NASH significantly impacts the life quality and life expectancy of chronic liver disease. Moreover, NASH is fatal since it involves the onset of multiple chronic disease and may cause cirrhosis and liver failure. Potentially more worrying, NASH does not show any obvious symptoms in early stages, therefore, a more effective and precise NASH diagnostic technique is necessary. This review introduces the current research status of NASH and summarizes the obstacles and potential solution in this research.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
